Reviewing the role of healthy volunteer studies in drug development

BACKGROUND: With the exception of genotoxic oncology drugs, first-in-human, Phase 1 clinical studies of investigational drugs have traditionally been conducted in healthy volunteers (HVs). The primary goal of these studies is to investigate the pharmacokinetics and pharmacodynamics of a novel drug c...

Descripción completa

Detalles Bibliográficos
Autores principales: Karakunnel, Joyson J., Bui, Nam, Palaniappan, Latha, Schmidt, Keith T., Mahaffey, Kenneth W., Morrison, Briggs, Figg, William D., Kummar, Shivaani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278009/
https://www.ncbi.nlm.nih.gov/pubmed/30509294
http://dx.doi.org/10.1186/s12967-018-1710-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278009/
https://www.ncbi.nlm.nih.gov/pubmed/30509294
http://dx.doi.org/10.1186/s12967-018-1710-5

Ejemplares similares